Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
3
Neutral
8
Bullish
3
Bearish
15
Neutral
12
Bullish
19
Bearish
12
Neutral
4
Bullish
16
Bearish
3
Neutral
8
Bullish
3
Bearish
3
Neutral
8
Bullish
3
Bearish
12
Neutral
4
Bullish
16
Bearish
12
Neutral
4
Bullish
16
Bearish
12
Neutral
4
Bullish
16
Mardia Samyoung Capillary Tubes Company Limited is a joint venture manufacturing capillary and thin-walled tubes from non-ferrous metals, including brass, stainless steel, and copper alloys.
The company has a manufacturing facility in Silvassa, with an operational capacity of 1800 tpa. Samyoung, S.Korea, a partner, also purchases 6000 tpa of finished products, enhancing international collaboration.
In 2015, a rehabilitation scheme led to the amalgamation of Mardia Tubes Ltd and Mardia Extrusions Ltd with the company, aiming to enhance shareholder value and achieve synergy among BIFR registered companies.
Mardia has undergone strategic diversification, altering its Object Clause in 2018-19 to include Art Dealership, showcasing its intent to explore new verticals beyond traditional manufacturing.
The company faced significant financial challenges in 1999, resulting in referral to BIFR, and conducted a feasibility study to address its operational and economic setbacks.
Non - Ferrous Metals
Copper
475 Cr
Low Risk
135.4
13.0
1.6
4.7
123.40
38.50
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
104.80 | 629 Cr | 46.94 | 2.29 | 0.00 | 4.74 | 7.02 | 3.69 | ||
288.80 | 589 Cr | 26.28 | 6.01 | 0.00 | 22.88 | 24.32 | 15.05 | ||
59.80 | 475 Cr | 135.38 | 4.68 | 0.00 | 2.37 | 3.71 | 3.69 | ||
364.95 | 364 Cr | 87.56 | 20.04 | 0.00 | 22.39 | 28.01 | 12.88 | ||
213.05 | 251 Cr | -78.55 | 0.76 | 0.00 | -2.50 | 0.79 | -0.64 | ||
35.50 | 233 Cr | 26.29 | 1.63 | 0.14 | 5.31 | 10.03 | 1.61 | ||
178.00 | 70 Cr | 9.10 | 3.86 | 0.00 | 35.44 | 26.49 | 7.80 | ||
| Median: 7 Co. | — | 178.00 | 364 Cr | 26.29 | 3.86 | 0.00 | 5.31 | 10.03 | 3.69 |
Mardia Samyoung Capillary Tubes Company Ltd (MSCTC) is currently trading at 58.61 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Mardia Samyoung Capillary Tubes Company Limited is a joint venture manufacturing capillary and thin-walled tubes from non-ferrous metals, including brass, stainless steel, and copper alloys. The company has a manufacturing facility in Silvassa, with an operational capacity of 1800 tpa. Samyoung, S.Korea, a partner, also purchases 6000 tpa of finished products, enhancing international collaboration. In 2015, a rehabilitation scheme led to the amalgamation of Mardia Tubes Ltd and Mardia Extrusions Ltd with the company, aiming to enhance shareholder value and achieve synergy among BIFR registered companies. Mardia has undergone strategic diversification, altering its Object Clause in 2018-19 to include Art Dealership, showcasing its intent to explore new verticals beyond traditional manufacturing. The company faced significant financial challenges in 1999, resulting in referral to BIFR, and conducted a feasibility study to address its operational and economic setbacks.
Over the past 52 weeks, Mardia Samyoung Capillary Tubes Company Ltd has traded between a low of ₹38.50 and a high of ₹123.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Mardia Samyoung Capillary Tubes Company Ltd has a market capitalization of approximately 475.18. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Mardia Samyoung Capillary Tubes Company Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 135.38 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 475.18 Cr, Mardia Samyoung Capillary Tubes Company Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Mardia Samyoung Capillary Tubes Company Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Mardia Samyoung Capillary Tubes Company Ltd is 135.38. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
